Terms: = Head and neck cancer AND MYO5A, Q9Y4I1, MYR12, MYO5, MYH12, GS1, ENSG00000197535, 4644
11 results:
1. myo5a overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
Xing J; Gu Y; Song Y; Liu Q; Chen Q; Han P; Shen Z; Li H; Zhang S; Bai Y; Ma J; Sui F
BMC Cancer; 2023 Dec; 23(1):1267. PubMed ID: 38129784
[TBL] [Abstract] [Full Text] [Related]
2. circFNDC3B promotes esophageal squamous cell carcinoma progression by targeting myo5a via miR-370-3p/miR-136-5p.
Song D; Ye Z; Chen F; Zhan L; Sun X
BMC Cancer; 2023 Sep; 23(1):821. PubMed ID: 37667251
[TBL] [Abstract] [Full Text] [Related]
3. Circ-FNDC3B Functions as an Oncogenic Factor in Esophageal Squamous Cell Carcinoma via Upregulating myo5a by Absorbing miR-136-5p and miR-370-3p.
Zhang Y; Xiong W; Yang C; Li P; Tong H
Biochem Genet; 2023 Oct; 61(5):1917-1936. PubMed ID: 36884165
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the head and neck.
Zhu Y; Zheng S; Zhai X; Wang C; Liu A; Ju J; Peng X; Chen L; Zhang Y; Ren N; Xie Y; Fan J; Zhao K; Liu M
J Immunol Res; 2022; 2022():5501476. PubMed ID: 35478939
[TBL] [Abstract] [Full Text] [Related]
5. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract] [Full Text] [Related]
6. LINC01980 facilitates esophageal squamous cell carcinoma progression via regulation of miR-190a-5p/myo5a pathway.
Liang X; Wu Z; Shen S; Niu Y; Guo Y; Liang J; Guo W
Arch Biochem Biophys; 2020 Jun; 686():108371. PubMed ID: 32325088
[TBL] [Abstract] [Full Text] [Related]
7. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract] [Full Text] [Related]
8. A systematic literature review of studies reporting human papillomavirus (HPV) prevalence in esophageal carcinoma over 36 years (1982-2017).
Hošnjak L; Poljak M
Acta Dermatovenerol Alp Pannonica Adriat; 2018 Sep; 27(3):127-136. PubMed ID: 30244262
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract] [Full Text] [Related]
10. Can a metastatic gene expression profile outperform tumor size as a predictor of occult lymph node metastasis in oral cancer patients?
Méndez E; Lohavanichbutr P; Fan W; Houck JR; Rue TC; Doody DR; Futran ND; Upton MP; Yueh B; Zhao LP; Schwartz SM; Chen C
Clin Cancer Res; 2011 Apr; 17(8):2466-73. PubMed ID: 21300763
[TBL] [Abstract] [Full Text] [Related]
11. Predictive factors of nodal metastases in oral cavity and oropharynx carcinomas.
Giacomarra V; Tirelli G; Papanikolla L; Bussani R
Laryngoscope; 1999 May; 109(5):795-9. PubMed ID: 10334233
[TBL] [Abstract] [Full Text] [Related]
